Nec Oncoimmunity AS
Score · fiscal year 2025
36of 100
How to read this: the company is ahead of 21 % of companies in the Morning class Small in the same sector in 2025. What does this mean?
Rank in the Morning class Small: 326 of 413 · What are Morning company classes?
Place in the whole sector: 1,569 of 2,025 · Informasjon og kommunikasjon
Profile
Elephant · Steward
Lower profitability, high solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 2 and solidity 81 out of 100 among companies in the Morning class Small in the same sector in 2025. Methodology
Against the sector
Nec Oncoimmunity AS is 14 points below the median for companies in the Morning class Small in the same sector in 2025.
Median score 50 among 413 companies.
Against companies in the Morning class Small in the same sector in 2025: operating margin −147.2% (median 5.2%) and equity ratio 60.6% (median 32.7%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 46 MNOK | 21 MNOK |
| Operating margin | −147.2% | 5.2% |
| Profit margin | −147.9% | 5.1% |
| Return on assets | −90.9% | 9.8% |
| Equity ratio | 60.6% | 32.7% |
| Debt-to-equity | 0.65 | 1.69 |
| Current ratio | 2.34 | 1.26 |
| Revenue growth | −37.4% | 8.2% |
| Revenue per employee | 1.39 MNOK | 1.92 MNOK |
The median and “ahead of” refer to companies in the Morning class Small in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 36, Nec Oncoimmunity AS does better than 21% of companies in the Morning class Small in the same sector (413 companies) in 2025.
Score 2023–2025
- Nec Oncoimmunity AS
- Median: companies in the Morning class Small in the same sector
Nec Oncoimmunity AS has a score of 36 for 2025, rank 1,569 of 2,025 in the sector.
Strongest: Liquidity: percentile 84 against peers, current ratio 2.34 against a median of 1.26. Solidity: percentile 81 against peers, equity ratio 60.6% against a median of 32.7%.
Weakest: Growth: percentile 2 against peers, revenue growth −37.4% against a median of 8.2%. Profitability: percentile 2 against peers, operating margin −147.2% against a median of 5.2%.
Worth a closer look
- The company made a loss before tax. Are these one-off items or a pattern? Based on: profit margin −147.9% (median 5.1%).
- The operating margin is lower than at three in four companies in the sector. Where do costs differ from competitors? Based on: operating margin −147.2% (median 5.2%).
- What lies behind weak growth, and will it last?
- What lies behind weak profitability, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
Nec Oncoimmunity AS had an operating margin of −147.2% and an equity ratio of 60.6% in 2025, and ranks 1,569 of 2,025 in Informasjon og kommunikasjon.
From 2024 to 2025: the operating margin fell from −62.9% to −147.2% and revenue fell by 37%.
This text is generated automatically from the 2025 accounts.
Three simple methods
One method gives a figure: 44 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | not meaningful |
| EV/EBIT | 8.0 | not meaningful |
| P/B | 1.0 | 44 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- watch
The company made a loss before tax. Are these one-off items or a pattern?
Based on: Profit margin −147.9% (median 5.1%).
- watch
The operating margin is lower than at three in four companies in the sector. Where do costs differ from competitors?
Based on: Operating margin −147.2% (median 5.2%).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 5.2% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
- watch Extreme margin: check the figures
Scenario analysis: the sector's weakest year
We have no accounts for 2026, the sector's weakest year, for this company.
The sector's weakest year was 2026, with a median operating margin of 4.1%. Based on the 8 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 2 | weight 30% |
|---|---|---|
| Solidity | 81 | weight 25% |
| Liquidity | 84 | weight 15% |
| Growth | 2 | weight 15% |
| Consistency | 12 | weight 15% |
Durability: 47 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is Nec Oncoimmunity AS?
The operating margin was −147.2% in 2025, against a median of 5.2% among companies in the Morning class Small in the same sector. Return on assets was −90.9%. The company made a loss before tax.
How solid is Nec Oncoimmunity AS?
The equity ratio was 60.6% in 2025 (median 32.7%). Debt-to-equity was 0.65 (median 1.69).
What is the liquidity of Nec Oncoimmunity AS like?
The current ratio was 2.34 in 2025 (median 1.26).
How does Nec Oncoimmunity AS compare in Informasjon og kommunikasjon?
Nec Oncoimmunity AS ranks 1,569 of 2,025 in Informasjon og kommunikasjon for 2025. Among companies in the Morning class Small it is number 326 of 413. Revenue changed by −37.4% from the year before.
From the Central Coordinating Register
- Org. no.
- 913062612
- Legal form
- AS
- Sector
- Informasjon og kommunikasjon (62.100)
- Morning company class
- Small
- Employees
- 33 registered 10 May 2026
- Founded
- 2 January 2014 12 years in operation
- Share capital
- 0.47 MNOK
- Business address
- Ullernchausséen 64, 0379 OSLO
- Municipality
- Oslo rank 63–220 of 357 in Norway
- Latest accounts filed
- 2025
- LEI
- 549300A52D5CLMB05003 not renewed (lapsed)
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Saverio Niccolini
- Chair of the board
- Saverio Niccolini
- Auditor
- KPMG AS
- Accountant
- Ecit Services AS
Source: Central Coordinating Register, fetched 31 October 2026. Only names are shown.
- Parent company
- No parent company: owned by persons
Source: GLEIF (Global Legal Entity Identifier Foundation), fetched 30 October 2026. The parent is the one the company itself reported to GLEIF.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 30 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 57 | 48 | 36 | |
| Rank | 693 | 1,117 | 1,569 | |
| Operating margin | −138.3% | −62.9% | −147.2% | |
| Return on assets | −46.5% | −48.7% | −90.9% | |
| Equity ratio | 83.0% | 52.0% | 60.6% | |
| Current ratio | 5.27 | 1.94 | 2.34 | |
| Revenue growth | – | 177.1% | −37.4% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 26.5 MNOK | 73.3 MNOK | 45.9 MNOK |
| Operating profit | −36.6 MNOK | −46.1 MNOK | −67.6 MNOK |
| Profit before tax | −36.4 MNOK | −45.0 MNOK | −67.9 MNOK |
| Net profit | −36.4 MNOK | −45.0 MNOK | −67.9 MNOK |
| Financial expenses | 2.4 MNOK | 2.2 MNOK | 1.5 MNOK |
| Total assets | 73.0 MNOK | 87.8 MNOK | 73.0 MNOK |
| Current assets | 65.3 MNOK | 81.7 MNOK | 67.3 MNOK |
| Equity | 60.7 MNOK | 45.7 MNOK | 44.2 MNOK |
| Retained earnings | – | – | – |
| Total liabilities | 12.4 MNOK | 42.1 MNOK | 28.8 MNOK |
| Current liabilities | 12.4 MNOK | 42.1 MNOK | 28.8 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 30 October 2026, accounts id 6354691.
Further
Similar companies
- Konciv AS index 36, rank 1,565 · compare
- Forlagstjenester AS index 35, rank 1,577 · compare
- Quantfolio AS index 35, rank 1,582 · compare
- Memcare AS index 35, rank 1,584 · compare
- Motitech AS index 35, rank 1,589 · compare